Congenital heart block in newborns of mothers with connective tissue disease

Insights

Maternal lupus erythematosus (LE) and associated antibodies are linked to congenital complete heart block (CCHB) in infants. This placental antibody transmission may cause fetal cardiac conduction system issues, even if the mother shows no symptoms.

Area of Science:

  • Immunology
  • Cardiology
  • Pediatrics

Background:

  • Congenital complete heart block (CCHB) is a serious condition affecting newborns.
  • Connective tissue diseases, particularly lupus erythematosus (LE), are implicated in CCHB.
  • Maternal autoantibodies, such as antinuclear antibodies (ANAs), can cross the placenta.

Purpose of the Study:

  • To investigate the association between maternal connective tissue disease, especially lupus erythematosus, and CCHB in children.
  • To explore the role of transplacental antibody transmission in the etiology of CCHB.

Main Methods:

  • Retrospective study of 22 children diagnosed with CCHB.
  • Review of maternal medical history and laboratory findings for evidence of connective tissue disease.
  • Analysis of antibody presence (ANAs, rheumatoid factor) and complement levels in mothers.

Main Results:

  • 14 out of 22 children (63.6%) with CCHB were born to mothers with clinical or laboratory evidence of connective tissue disease, primarily LE.
  • Seven mothers had both clinical and laboratory evidence of LE; four had only positive laboratory markers.
  • Maternal autoantibodies, including IgG ANAs, were identified as potential culprits.

Conclusions:

  • Maternal lupus erythematosus and associated autoantibodies are a significant risk factor for CCHB in offspring.
  • Placental transfer of maternal IgG autoantibodies may directly impact the fetal cardiac conduction system, leading to CCHB.
  • CCHB can occur even when the mother is asymptomatic during pregnancy, highlighting the importance of antibody screening.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...